Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000103

Chief Executive Officer sold 11,449 shares at $28.36 ($324,694)

  • Chief Executive Officer acquired 25,528 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goff Brian · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-28 Exercise or conversion : show line 1 in the form 10b5-1 +25,528 25,528 D
2023-06-30 Sale : show line 2 in the form 10b5-1 −11,449 $28.36 $324,694 14,079 D
Open-market sales · 11,449 sh · avg $28.36 · $324,694

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-28 Exercise or conversion : show line 3 in the form 10b5-1 Performance share units −25,528 144,655 D
Loading xslF345X04/wk-form4_1688155500.xml…